查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715734

数位 PCR 和即时PCR市场按产品类型、技术、样本类型、应用和最终用户划分——2025 年至 2030 年全球预测

Digital PCR & Real-Time PCR Market by Product Type, Technology, Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年数位PCR和即时PCR市场价值将达到151亿美元，2025年将达到164.2亿美元，复合年增长率为9.01%，到2030年将达到253.5亿美元。

执行摘要：数位PCR和即时PCR的应用前景

主要市场统计数据
基准年2024年 151亿美元
预计2025年 164.2亿美元
预测年份 2030 253.5亿美元
复合年增长率（%） 9.01%

在快速发展的分子诊断和研究领域，数位 PCR 与传统即时PCR技术的出现标誌着一个重要的转折点。这份综合报告探讨了创新的数位 PCR 方法与广泛实施的即时PCR技术之间的动态相互作用，后者长期以来一直是基因分析的基石。随着对核酸分析的精度、灵敏度和定量要求的不断提高，在严谨的研究、技术整合和创新应用的推动下，这些技术正在经历变革性的转变。

对于热衷于利用先进遗传工具进行临床、环境和研究应用的相关人员来说，了解数位 PCR 和即时PCR现状至关重要。随着自动化、数据分析和小型化的发展趋势，该领域不仅有望提高诊断能力，而且还将加速从研究到现实世界医疗和工业应用的进程。该报告透过細項分析、区域趋势和关键产业参与者的研究提供了宝贵的见解，为 PCR 技术领域的策略性投资和未来创新奠定了基础。

变革数位PCR与即时PCR市场

目前数位 PCR 和即时PCR的市场环境以技术不断进步为推动力，不断发生转型转变。在过去的十年中，重大进展带来了灵敏度、精确度和吞吐量的提高，从而使研究人员和临床医生即使在具有挑战性的样本条件下也能获得更可靠的结果。

从传统扩增方法到精确数位量化平台的演进等技术突破重新定义了实验室工作流程。先进的数据分析和自动化系统的整合，不仅提高了工作效率，也扩大了应用范围。一个显着的变化是从本体扩增技术转向基于微流体的技术，该技术可以以无与伦比的精度对极低浓度的核酸进行量化。

此外，生物技术和自动化的融合为可扩展的高通量分析铺平了道路。这种转变在临床诊断中尤其明显，因为快速的周转时间和准确性至关重要，并且在需要单细胞分析和复杂基因表现研究的研究场景中也是如此。仪器设计、试剂品质和软体方面的平行创新为分子诊断工具性能设定了新的标准，开创了精度、速度与可操作洞察力相结合的时代。

研发投入增加、监管部门核准以及新兴市场强劲需求等市场力量正在进一步推动这一转变。这些因素的交织支持了永续的成长轨迹，并促进了数位 PCR 和即时PCR的持续创新。

市场分析的关键细分洞察

详细的細項分析揭示了多方面的观点，这对于理解 PCR 技术市场的细微差别至关重要。市场已根据产品类型进行了研究，并对仪器、试剂、消耗品、服务和软体进行了全面评估。具体来说，试剂和耗材部门专注于酵素、主混合物以及探针和引物，以帮助相关人员确定准确的性能指标和成本驱动因素。

除了产品类型之外，透过比较数位 PCR 和即时PCR，技术细分提供了双重视角。数位PCR又可分为基于晶片的数位PCR和液滴数位PCR，各有各的优点和应用领域；即时PCR又可分为定量即时PCR和逆转录即时PCR。这种区别使得可以针对性地投资于满足临床诊断和研究环境精确需求的平台。

分析还涉及样本类型，包括血液、环境、食物和组织频谱。对于血液样本，血浆和血清之间的细微评估可以深入了解样本特定的挑战和机会。环境样本进一步分为土壤和水类型，强调需要多样化的调查方法来适应样本物理和化学性质的变化。

基于应用的细分透过详细说明临床、环境、食品安全、法医学、调查等多种用途发挥至关重要的作用。在临床应用中，传染病检查、肿瘤学检测和移植诊断等专业凸显了该技术彻底改变患者照护的潜力。这进一步补充了以过敏原和病原体测试为重点的食品安全应用的评估，以及深入基因表现、单细胞分析和干细胞研究领域的研究应用。

最后，最终用户细分揭示了该技术在学术和研究机构、临床诊断实验室、法医学实验室以及製药和生物技术公司中的分布。事实证明，这种细分对于了解不同行业之间的不同需求和使用模式至关重要，从而可以更好地进行产品开发和上市。总的来说，这些细分见解提供了了解当前市场动态以及新兴 PCR 技术未来机会和挑战所需的详细资讯。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 感染疾病的传播推动了对准确、及时的诊断解决方案的需求
      • 人们对个人化医疗和客製化治疗的日益关注推动了 PCR 技术的应用。
      • 遗传和基因组研究的扩展增加了对 PCR 等精确定量工具的需求。
    • 限制因素
      • 数位和即时PCR仪器的高成本及其校准和维护
    • 机会
      • 提高 PCR 分析技术灵敏度、效率和速度的技术进步
      • PCR在食品安全检测和农业生物技术中的应用日益广泛，扩大了市场机会
    • 任务
      • 技术复杂性以及缺乏数位和即时PCR技术的熟练专家
  • 市场区隔分析
    • 技术：利用数位PCR技术提高分子诊断准确性
    • 最终用户：透过整合 PCR 技术在学术研究机构中推动科学发现
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 数位PCR和即时PCR市场（按产品类型）

  • 装置
  • 试剂和耗材
    • 酵素
    • 预混液
    • 探针和引子
  • 服务
  • 软体

7. 数位PCR和即时PCR市场（按技术）

  • 数位PCR
    • 基于晶片的数位PCR
    • 液滴式数位PCR
  • 即时PCR
    • 定量即时PCR（qPCR）
    • 逆转录即时PCR（RT-qPCR）

8. 数位PCR和即时PCR市场（按样本类型）

  • 血液样本
    • 电浆
    • 血清
  • 环境样品
    • 土壤样本
    • 水样
  • 食品样品
  • 组织样本

第九章数位PCR和即时PCR市场（按应用）

  • 临床应用
    • 传染病检查
    • 肿瘤学检测
    • 移植诊断
  • 环境应用
  • 食品安全
    • 过敏原检测
    • 病原体检测
  • 法医学应用
  • 调查应用
    • 基因表现
    • 单细胞分析
    • 干细胞研究

第 10 章 数位 PCR 和即时PCR市场（按最终用户）

  • 学术研究所
  • 临床诊断实验室
  • 法医学实验室
  • 製药和生物技术公司

11.美洲数位PCR和即时PCR市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区数位PCR和即时PCR市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲数位PCR和即时PCR市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocompare
  • BIOMERIEUX SA
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group by Bruker Corp
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Etcon Analytical and Environmental Systems & Services Ltd.
  • Explorea sro
  • F. Hoffmann-La Roche Ltd.
  • Hangzhou Longgene Scientific Instruments Co., Ltd.
  • Heal Force Bio-Meditech Holdings Limited
  • LABGENE Scientific SA
  • Merck KGaA
  • Promega Corporation
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • RainSure Scientific
  • SD Biosensor, Inc.
  • Solis BioDyne OU
  • STANDARD BIOTOOLS INC.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market was valued at USD 15.10 billion in 2024 and is projected to grow to USD 16.42 billion in 2025, with a CAGR of 9.01%, reaching USD 25.35 billion by 2030.

Executive Summary: Introduction to Digital PCR & Real-Time PCR Landscape

KEY MARKET STATISTICS
Base Year [2024] USD 15.10 billion
Estimated Year [2025] USD 16.42 billion
Forecast Year [2030] USD 25.35 billion
CAGR (%) 9.01%

In the rapidly evolving world of molecular diagnostics and research, the emergence of digital PCR alongside traditional real-time PCR technology marks a significant turning point. This comprehensive report explores the dynamic interplay between innovative digital PCR methodologies and the widely implemented real-time PCR techniques that have long been the cornerstone of genetic analysis. As the demand for greater precision, sensitivity, and quantification in nucleic acid analysis grows, these technologies have seen transformative shifts in adoption, driven by rigorous research, technological integrations, and innovative applications.

Understanding the landscape of digital and real-time PCR is essential for stakeholders keen on harnessing advanced genetic tools for clinical, environmental, and research applications. With growing trends in automation, data analysis, and miniaturization, the field not only promises enhanced diagnostic capabilities but also accelerates the path from research to real-world medical and industrial applications. This report provides valuable insights through segmentation analysis, regional trends, and an examination of key industry players, setting the stage for strategic investments and future innovations in the arena of PCR technology.

Transformative Shifts in the Digital PCR & Real-Time PCR Landscape

The current market environment for digital PCR and real-time PCR is characterized by transformative shifts fueled by continuous technological enhancements. Over the last decade, significant advancements have led to improved sensitivity, accuracy, and throughput, thereby enabling researchers and clinicians to obtain more reliable results even in challenging sample conditions.

Technological breakthroughs, such as the evolution from conventional amplification methods to precise digital quantification platforms, have redefined experimental workflows. The integration of advanced data analytics and automation systems has not only increased operational efficiency but has also expanded the range of applications. Notable changes include the migration from bulk amplification techniques to microfluidic-based technologies that allow for unparalleled precision in the quantification of nucleic acids at very low concentrations.

Furthermore, the convergence of biotechnology and automation has paved the way for scalable high-throughput assays. This shift has been particularly evident in clinical diagnostics where rapid turnaround times and accuracy are paramount, as well as in research scenarios requiring single-cell analysis and complex gene expression studies. The parallel improvements in instrument design, reagent quality, and software innovations have collectively set a new standard in the performance of molecular diagnostics tools, marking an era where precision and speed coalesce into actionable insights.

Market forces such as increased R&D investments, regulatory approvals, and robust demand in emerging economies are further fueling this transformation. The intersection of these factors supports a sustainable growth trajectory and encourages continuous innovation in both digital PCR and real-time PCR technologies.

Key Segmentation Insights for Market Analysis

An in-depth segmentation analysis reveals multifaceted perspectives that are vital for understanding the nuances of the PCR technology market. The market is studied based on product type, where a comprehensive evaluation differentiates between instruments, reagents and consumables, services, and software. Specifically, within the reagents and consumables segment, the focus on enzymes, master mixes, and probes and primers has helped stakeholders pinpoint precise performance indicators and cost drivers.

In addition to the product type, the technology segmentation provides a dual outlook by comparing digital PCR and real-time PCR. Digital PCR is partitioned further into chip-based digital PCR and droplet digital PCR, each with its unique strengths and application areas, while real-time PCR is further categorized into quantitative real-time PCR and reverse transcription real-time PCR. Such distinctions allow for targeted investments in platforms that meet the precise needs of clinical diagnostics and research environments.

The analysis also extends to sample type, covering a spectrum that includes blood, environmental, food, and tissue samples. Within blood samples, nuanced evaluations between plasma and serum have offered insights into sample-specific challenges and opportunities. Environmental samples are further dissected into soil and water types, emphasizing the need for diverse methodological adaptations to suit varying physical and chemical properties of the samples.

Application-based segmentation plays a critical role by detailing diverse uses such as clinical, environmental, food safety, forensic, and research applications. Within clinical applications, specialties like infectious disease testing, oncology testing, and transplant diagnostics highlight the technology's potential to revolutionize patient care. This is further complemented by the evaluation of food safety applications focusing on allergen and pathogen testing, as well as research applications that delve into areas of gene expression, single cell analysis, and stem cell research.

Finally, the end-user segmentation sheds light on the distribution of technology across academic and research institutes, clinical diagnostics laboratories, forensic labs, and pharmaceutical and biotechnology companies. This segmentation has proven integral to understanding the differing demands and usage patterns across various sectors, enabling a more tailored approach to product development and market deployment. Overall, these segmentation insights provide the granular detail needed to understand not only the current market dynamics but also the future potential and challenges of emerging PCR technologies.

Based on Product Type, market is studied across Instruments, Reagents & Consumables, Services, and Software. The Reagents & Consumables is further studied across Enzymes, Master Mixes, and Probes & Primers.

Based on Technology, market is studied across Digital PCR and Real-Time PCR. The Digital PCR is further studied across Chip-Based Digital PCR and Droplet Digital PCR. The Real-Time PCR is further studied across Quantitative Real-Time PCR (qPCR) and Reverse Transcription Real-Time PCR (RT-qPCR).

Based on Sample Type, market is studied across Blood Samples, Environmental Samples, Food Samples, and Tissue Samples. The Blood Samples is further studied across Plasma and Serum. The Environmental Samples is further studied across Soil Samples and Water Samples.

Based on Application, market is studied across Clinical Applications, Environmental Applications, Food Safety, Forensic Application, and Research Applications. The Clinical Applications is further studied across Infectious Disease Testing, Oncology Testing, and Transplant Diagnostics. The Food Safety is further studied across Allergen Testing and Pathogen Testing. The Research Applications is further studied across Gene Expression, Single Cell Analysis, and Stem Cell Research.

Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostics Laboratories, Forensic Labs, and Pharmaceutical & Biotechnology Companies.

Regional Trends Shaping the Digital PCR & Real-Time PCR Market

The regional dynamics of the market reveal distinct trends that vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, there is a steady increase in regulatory acceptance and reimbursement policies that bolster the adoption of advanced PCR technologies in clinical settings. This region marks substantial advancements in both research and diagnostic services, driven by robust investments in healthcare infrastructure and a strong network of academic institutions.

Across Europe, the Middle East, and Africa, collaborative efforts among institutions, universities, and government agencies have accelerated the integration of digital and real-time PCR technologies. Here, emphasis is placed not only on research but also on public health applications, particularly the drive towards better disease screening and environmental monitoring. Markets in these regions have seen a rapid evolution due to increased funding for R&D and a willingness to adopt innovative diagnostic technologies.

In the Asia-Pacific, accelerated economic growth and rapid modernization of healthcare services have positioned the region as a hub for technological adoption and innovation. The integration of PCR techniques in both large-scale industrial settings and smaller, agile research facilities has resulted in a diverse market landscape. This area is particularly noted for its strong focus on cost efficiency and the adaptation of technologies that can cater to varying economic contexts. Overall, the interplay of regional policies, economic drivers, and technological readiness across these regions creates a fertile environment for sustained growth in the PCR market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Steering Innovation and Competition

A closer look at the competitive landscape highlights several key companies that have left an indelible mark on the evolution and direction of PCR technology. Companies such as Abbott Laboratories, Inc. and Agilent Technologies, Inc. have been instrumental in driving innovation in both digital and real-time PCR platforms, balancing the demands for high-throughput instrumentation with cost-effective solutions. Analytik Jena GmbH+Co. KG and Azure Biosystems Inc. also feature prominently, underscoring a commitment to refining technology that enhances both accuracy and usability.

Continuing this trend, Becton, Dickinson and Company and Bio-Rad Laboratories, Inc. have consistently demonstrated leadership through technological integrations that streamline workflows in clinical laboratories. The extensive contributions from BIOMERIEUX S.A. and Bioneer Corporation further accentuate the competitive drive present in this dynamic market. Not far behind, Danaher Corporation and ELITech Group by Bruker Corp provide state-of-the-art solutions that facilitate faster diagnostics and research analysis.

Other notable players including Enzo Life Sciences, Inc., Eppendorf SE, and Etcon Analytical and Environmental Systems & Services Ltd. deliver reliable and innovative products tailored to meet the rigorous needs of both academic research and industrial applications. Explorea s.r.o, F. Hoffmann-La Roche Ltd., and Hangzhou Longgene Scientific Instruments Co., Ltd. are continually pushing the boundaries of technology with a focus on precision and efficiency.

The landscape is further enriched by contributions from Heal Force Bio-Meditech Holdings Limited, LABGENE Scientific SA, and Merck KGaA, who are known for their robust product pipelines and expansive geographic footprints. Leaders from Promega Corporation and QIAGEN N.V. have streamlined the integration of digital platforms with traditional PCR, while Quidel Corporation, R-Biopharm AG, and RainSure Scientific have consistently met the evolving demands of diagnostic testing. Additional significant innovators such as SD Biosensor, Inc., Solis BioDyne OU, and STANDARD BIOTOOLS INC. have set high standards in quality and performance. The contributions of Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp. further underscore the innovative spirit and competitive drive that continue to shape the industry. Their combined efforts not only reflect the current state of the market but also pave the way for new advancements in PCR-based methodologies.

The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare, BIOMERIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group by Bruker Corp, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche Ltd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, LABGENE Scientific SA, Merck KGaA, Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, SD Biosensor, Inc., Solis BioDyne OU, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.. Actionable Recommendations for Industry Leaders

Industry leaders aiming to leverage the full potential of PCR technologies must focus on several strategic areas. Investing in research and development to foster greater integration of digital platforms with conventional methodologies is paramount. The convergence of emerging software solutions with state-of-the-art instrumentation should be a priority, as it allows for seamless data integration, improved workflow automation, and enhanced result accuracy.

Leaders should also consider diversifying their product portfolios to encompass the varied aspects of segmentation such as product types, technology formats, sample types, and application-specific needs. Embracing a tailored approach towards the reagents and consumables segment-particularly refining focus on enzymes, master mixes, and probes and primers-can yield significant competitive advantages. By aligning efforts to cater to both chip-based and droplet digital PCR, as well as quantitative and reverse transcription real-time PCR, companies can ensure their offerings meet the diverse demands of clinical diagnostics and cutting-edge research.

It is equally important for industry stakeholders to invest in training and support services to foster effective adoption of new platforms. This includes enhancing customer education on technological capabilities and integrating feedback mechanisms to rapidly adapt to emerging requirements. Additionally, expanding market reach by targeting distinct end-user segments, including academic and research institutes, clinical diagnostic laboratories, forensic labs, and pharmaceutical and biotechnology companies, will facilitate broader acceptance and usage of advanced PCR technologies.

Staying ahead in a competitive market also requires continuous monitoring of regulatory and reimbursement conditions across different regions. Keeping abreast of evolving guidelines can help companies not only comply with standards but also take advantage of emerging opportunities in markets that prioritize rapid diagnostics and patient care. Finally, forging strategic partnerships with research institutions and key opinion leaders will help accelerate technological adoption and advance market presence. These actionable recommendations, crafted to foster innovation, operational excellence, and enhanced customer engagement, provide a roadmap for industry leaders seeking to unlock the full potential of modern PCR technology.

Conclusion: Embracing the Future of PCR Technology

In summary, the landscape of PCR technology, encompassing both digital and real-time formats, is characterized by continuous innovation and transformative market shifts. The convergence of cutting-edge instrumentation, refined reagent solutions, and robust software has set unprecedented standards in diagnostic accuracy and research capabilities. The detailed segmentation analysis underscores the tactical importance of addressing diverse facets of the market-from product type and technology to sample type, application areas, and end-user requirements. This comprehensive approach not only reflects the current trends but also captures the future potential inherent in the evolution of PCR methodologies.

The regional insights further underscore the role of geographically driven dynamics where regions like the Americas, Europe, Middle East & Africa, and Asia-Pacific contribute uniquely to market growth through tailored regulatory frameworks and investment in healthcare infrastructure. Meanwhile, the competitive landscape, spearheaded by industry leaders such as Abbott Laboratories, Inc., Agilent Technologies, Inc., and numerous other innovators, exemplifies the relentless pursuit of excellence and adaptation.

Embracing these insights and traversing the challenges of the modern diagnostic arena calls for a balanced mix of technological foresight and strategic agility. The future of PCR technology is not only about the evolution of the instruments and reagents but also about a shift in paradigms that integrates deep analytics, enhanced automation, and a commitment to precise diagnostic outcomes. Stakeholders who adapt quickly to these shifting market dynamics will be better positioned to lead in this arena.

Ultimately, the confluence of innovation, strategic segmentation, and regional adaptability creates an environment ripe for continuous growth and improved patient care. Leaders equipped with actionable insights and a forward-looking approach can harness these opportunities to pioneer advancements that redefine the landscape of molecular diagnostics and research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of infectious diseases fueling the need for precise and timely diagnostic solutions
      • 5.1.1.2. Growing focus on personalized medicine and tailored therapies boosting the use of PCR technologies
      • 5.1.1.3. Expansion of genetic and genomic research promoting the need for accurate quantification tools like PCR
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of digital and real-time PCR equipment along with their calibration and maintenance
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements enhancing the sensitivity, efficiency, and speed of PCR analysis techniques
      • 5.1.3.2. Increased application of PCR in food safety testing and agriculture biotechnology expanding market opportunities
    • 5.1.4. Challenges
      • 5.1.4.1. Technological complexities and shortage of skilled professionals in digital and real-time PCR technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Advancing precision in molecular diagnostics with digital PCR technology
    • 5.2.2. End-User: Advancing scientific discovery through the integration of pcr technologies in academic and research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital PCR & Real-Time PCR Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
    • 6.3.1. Enzymes
    • 6.3.2. Master Mixes
    • 6.3.3. Probes & Primers
  • 6.4. Services
  • 6.5. Software

7. Digital PCR & Real-Time PCR Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital PCR
    • 7.2.1. Chip-Based Digital PCR
    • 7.2.2. Droplet Digital PCR
  • 7.3. Real-Time PCR
    • 7.3.1. Quantitative Real-Time PCR (qPCR)
    • 7.3.2. Reverse Transcription Real-Time PCR (RT-qPCR)

8. Digital PCR & Real-Time PCR Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Samples
    • 8.2.1. Plasma
    • 8.2.2. Serum
  • 8.3. Environmental Samples
    • 8.3.1. Soil Samples
    • 8.3.2. Water Samples
  • 8.4. Food Samples
  • 8.5. Tissue Samples

9. Digital PCR & Real-Time PCR Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Applications
    • 9.2.1. Infectious Disease Testing
    • 9.2.2. Oncology Testing
    • 9.2.3. Transplant Diagnostics
  • 9.3. Environmental Applications
  • 9.4. Food Safety
    • 9.4.1. Allergen Testing
    • 9.4.2. Pathogen Testing
  • 9.5. Forensic Application
  • 9.6. Research Applications
    • 9.6.1. Gene Expression
    • 9.6.2. Single Cell Analysis
    • 9.6.3. Stem Cell Research

10. Digital PCR & Real-Time PCR Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Clinical Diagnostics Laboratories
  • 10.4. Forensic Labs
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Americas Digital PCR & Real-Time PCR Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Digital PCR & Real-Time PCR Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Digital PCR & Real-Time PCR Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. QIAGEN launches QIAcuityDx digital PCR system to transform clinical oncology with precision medicine
    • 14.3.2. Transasia-Erba pioneers high-accuracy MonkeyPox RT-PCR kit with robust global production capability
    • 14.3.3. GCCL's pioneering introduction of ddPCR technology in South Korea transforms clinical trial sample analysis
    • 14.3.4. Bio-Rad's advanced multiplexed digital PCR assay revolutionizes breast cancer mutation detection
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH+Co. KG
  • 4. Azure Biosystems Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biocompare
  • 8. BIOMERIEUX S.A.
  • 9. Bioneer Corporation
  • 10. Danaher Corporation
  • 11. ELITech Group by Bruker Corp
  • 12. Enzo Life Sciences, Inc.
  • 13. Eppendorf SE
  • 14. Etcon Analytical and Environmental Systems & Services Ltd.
  • 15. Explorea s.r.o
  • 16. F. Hoffmann-La Roche Ltd.
  • 17. Hangzhou Longgene Scientific Instruments Co., Ltd.
  • 18. Heal Force Bio-Meditech Holdings Limited
  • 19. LABGENE Scientific SA
  • 20. Merck KGaA
  • 21. Promega Corporation
  • 22. QIAGEN N.V.
  • 23. Quidel Corporation
  • 24. R-Biopharm AG
  • 25. RainSure Scientific
  • 26. SD Biosensor, Inc.
  • 27. Solis BioDyne OU
  • 28. STANDARD BIOTOOLS INC.
  • 29. Takara Bio USA, Inc.
  • 30. Thermo Fisher Scientific Inc.
  • 31. Zymo Research Corp.

LIST OF FIGURES

  • FIGURE 1. DIGITAL PCR & REAL-TIME PCR MARKET MULTI-CURRENCY
  • FIGURE 2. DIGITAL PCR & REAL-TIME PCR MARKET MULTI-LANGUAGE
  • FIGURE 3. DIGITAL PCR & REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 4. DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PCR & REAL-TIME PCR MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 307. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-T